SEC Form 4 · accession 0001600255-15-000002
Immunoclin Corp · IMCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chad Steven Johnson
Officer — Secretary/COO/General Counsel · Director
Period of report
Jan 1, 2015
Accepted (ET)
Jan 15, 2015 · 6:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520047
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,000,000 | D | ||
| Series A Preferred Stock | holding | — | — | — | 30,000 | I | Held by CSJ Group LLC, a company which Mr. Johnson has voting and investment control over. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Options | $1.45 | Jan 1, 2015 | A | 500,000 | A | Jan 1, 2015 | Nov 1, 2019 | Common Stock | 500,000 | 500,000 | D |